Ame Company For Medical Supplies
TADAWUL:9527.SR
93 (SAR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| 33.515 | 26.684 | 21.223 | 21.071 | 14.811 |
| Depreciation & Amortization
| 1.535 | 0.854 | 0.459 | 0.292 | 0.109 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -5.069 | -17.64 | -7.877 | -14.161 | -5.383 |
| Accounts Receivables
| -13.357 | -0.296 | -13.059 | -14.081 | 3.405 |
| Inventory
| 1.28 | -21.557 | -2.982 | 1.153 | -9.57 |
| Accounts Payables
| 0.511 | -0.247 | 0.245 | -5.853 | 1.548 |
| Other Working Capital
| 6.497 | 4.46 | 7.92 | 4.619 | -0.767 |
| Other Non Cash Items
| 6.67 | -1.424 | 6.459 | 23.781 | 6.292 |
| Operating Cash Flow
| 36.652 | 8.474 | 20.264 | 11.618 | 10.994 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -1.934 | -0.814 | -0.335 | -0.305 | -0.191 |
| Acquisitions Net
| 0 | 0 | 0.076 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| -1.934 | -0.814 | -0.26 | -0.305 | -0.191 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | -4.5 | -4.5 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -13.99 | -12.25 | -1.6 | 0 | 0 |
| Other Financing Activities
| -0.647 | -0.505 | -0.188 | -8.858 | -11.486 |
| Financing Cash Flow
| -14.637 | -12.755 | -6.288 | -4.545 | -11.616 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 20.082 | -5.096 | 13.717 | 6.768 | -0.813 |
| Cash At End Of Period
| 43.403 | 23.321 | 28.417 | 14.7 | 7.931 |